Teva Pharmaceuticals will sell a generic copy of Mylan’s EpiPen, which became the target of public outrage over its price. The New York Times By SHEILA KAPLAN from NYT Health https://ift.tt/2Mhhl8y August 15, 2018 at 02:00PM
No comments:
Post a Comment